AR and posterior cortical atrophy: Yet, the results from this plasmid-based assay strongly correlate with epigenetic features in both PCa cell lines and clinical tumors, suggesting that the enhancer capability of the individual CRE is predictive of steady-state AR enhancer activity in situ (Figs. 1e and 2b).